Edition:
India

Drug Retailers

Page 1

Galenica Is Adapting Its Organisational And Management Structure As Of 1 January 2021

Tuesday, 1 Dec 2020

Dec 1 (Reuters) - GALENICA AG ::GALENICA IS ADAPTING ITS ORGANISATIONAL AND MANAGEMENT STRUCTURE AS OF 1 JANUARY 2021.EXECUTIVE COMMITTEE TO BE COMPOSED OF MEMBERS OF CURRENT CORPORATE EXECUTIVE COMMITTEE AND WILL BE JOINED BY VIRGINIE PACHE JESCHKA.THERE WILL NO LONGER BE ANY BUSINESS SECTORS (TODAY'S RETAIL, PRODUCTS & BRANDS AND SERVICES).

New Ray Medicine International Says Served A Petition By Securities And Futures Commission

Wednesday, 18 Nov 2020

Nov 18 (Reuters) - New Ray Medicine International Holding Ltd <6108.HK>::WAS SERVED A PETITION FILED IN HIGH COURT OF HONG KONG SAR BY SECURITIES AND FUTURES COMMISSION.NO ORDER OR RELIEF IS SOUGHT AGAINST CO IN THE PETITION.CO SEEKING LEGAL ADVICE IN RESPECT OF PETITION.SFC NAMED 3 RESPONDENTS; APART FROM CO, OTHER 2 RESPONDENTS IN PETITION ARE 2 FORMER DIRECTORS OF CO.

Sunlink Health Systems, Inc. Reports Q1 Loss Per Share $0.04 From Continuing Operations

Friday, 13 Nov 2020

Nov 13 (Reuters) - SunLink Health Systems Inc ::SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FISCAL 2021 FIRST QUARTER RESULTS AND COVID-19 UPDATE.Q1 LOSS PER SHARE $0.04 FROM CONTINUING OPERATIONS.Q1 REVENUE $10.42 MILLION.SUNLINK HEALTH SYSTEMS - CURRENTLY BELIEVE WE MAY NOT BE ABLE TO UTILIZE PORTION OF PRF FUNDS RECEIVED UNDER CURRENTLY EXISTING INTERPRETATIONS BY HHS.

China Jo-Jo Drugstores Reports Q2 Loss Per Share $0.04

Friday, 13 Nov 2020

Nov 13 (Reuters) - China Jo-Jo Drugstores Inc ::CHINA JO-JO DRUGSTORES REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.04.Q2 REVENUE ROSE 8.8 PERCENT TO $30.84 MILLION.

Sinco Pharmaceuticals Appoints Jin Min Appointed As Co-CEO

Friday, 6 Nov 2020

Nov 6 (Reuters) - Sinco Pharmaceuticals Holdings Ltd <6833.HK>::ANNOUNCES THAT JIN MIN APPOINTED AS A CO-CHIEF EXECUTIVE OFFICER.

Cardinal Health Reports First Quarter Fiscal 2021 Results

Thursday, 5 Nov 2020

Nov 5 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS FIRST QUARTER FISCAL 2021 RESULTS.Q1 NON-GAAP EARNINGS PER SHARE $1.51.Q1 GAAP LOSS PER SHARE $0.86.Q1 REVENUE $39.1 BILLION VERSUS REFINITIV IBES ESTIMATE OF $38.18 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $1.13 -- REFINITIV IBES DATA.SEES FY NON-GAAP EARNINGS PER SHARE $5.65 TO $5.95.COMPANY RAISES FY21 EARNINGS GUIDANCE.FY2021 EARNINGS PER SHARE VIEW $5.50 -- REFINITIV IBES DATA.IN Q1 OF FISCAL YEAR 2021, COMPANY INCURRED A PRE-TAX CHARGE OF $1.02 BILLION.Q1 PRE-TAX CHARGE IS IN CONNECTION WITH OPIOID LAWSUITS AND DISCUSSIONS.Q1 REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 5% TO $35.1 BILLION.

HLS Therapeutics Inc Reports Q3 Net Loss $0.05 Per Common Share

Thursday, 5 Nov 2020

Nov 5 (Reuters) - HLS Therapeutics Inc ::HLS THERAPEUTICS ANNOUNCES Q3 2020 FINANCIAL RESULTS AND NORMAL COURSE ISSUER BID.HLS THERAPEUTICS INC - QTRLY NET LOSS WAS $0.05 PER COMMON SHARE.HLS THERAPEUTICS INC - QTRLY REVENUE $13.1 MILLION VERSUS $13.4 MILLION.HLS THERAPEUTICS INC - NORMAL COURSE ISSUER BID BECOMES EFFECTIVE NOVEMBER 9, 2020.

Shop Apotheke Europe Raises Its 2020 Guidance

Thursday, 5 Nov 2020

Nov 5 (Reuters) - SHOP APOTHEKE EUROPE NV ::CONTINUES ITS DYNAMIC GROWTH COURSE AND AGAIN RAISES ITS 2020 GUIDANCE..GUIDANCE FOR 2020: FULL-YEAR SALES GROWTH AT LEAST 35% (UP FROM PREVIOUSLY: AT LEAST 30%); ADJUSTED. EBITDA MARGIN AROUND 2% (UP FROM PREVIOUSLY: BETWEEN 1-2%)..SUCCESSFUL EARLIER CONVERSION OF EUR 135 MILLION CONVERTIBLE BONDS.INFRASTRUCTURE GETTING READY FOR FURTHER FUTURE GROWTH: FIRST CUSTOMER ORDER SENT FROM NEW LOGISTICS CENTRE IN SEVENUM AHEAD OF SCHEDULE IN OCTOBE.ADJUSTED. EBITDA MARGIN POSITIVE FOR THIRD CONSECUTIVE QUARTER: 1.8% IN Q3, 2.2% OR EUR 15.5 MILLION YTD.SALES UP 39.7% IN Q3; DACH SEGMENT SALES +32%, INTERNATIONAL SEGMENT +82%.

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary